142 results
8-K
EX-99.2
LUMO
Lumos Pharma Inc
5 Jun 24
Lumos Pharma Announces New Analyses of Phase 2
4:09pm
and spend in developing regions Very mature market Pricing pressures Inconsistent reimbursement policies K e y G ro w th D ri v e rs K e y H u rd le s Key
8-K
EX-99.1
dnykrrql ed
15 Nov 23
Other Events
4:38pm
8-K
EX-99.2
9husnv4b99 mva
14 Nov 22
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
6:55am
8-K
EX-99.2
7ne w72gaej8
10 Aug 22
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
12:00am